"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug,"
International hair loss experts reached consensus on low-dose oral minoxidil for alopecia in adults and adolescents, but not children under 12, in a modified Delphi study.